Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01101Capecitabine1Withdrawn1
DB00254Doxycycline1Active Not Recruiting1
DB09078Lenvatinib1Withdrawn1
DB09037Pembrolizumab1Active Not Recruiting1
DB18694ISA101b2Terminated1
DB15113Utomilumab2Terminated1